News about Drug Discovery & Development

TUL Signs Exclusive License Deal with Novo Nordisk for UBT251

Under the license agreement, Novo Nordisk will obtain exclusive worldwide rights (excluding Chinese mainland, Hong Kong, Macau, and Taiwan) to develop, manufacture, and commercialize UBT251.

Drug Discovery & Development | 25/03/2025 | By Aishwarya |  476

Everest Medicines Receives FDA Clearance of IND Application for EVM14

EVM14 is an off-the-shelf mRNA cancer vaccine targeting multiple TAAs and is designed to treat various cancers, including non-small cell lung cancer and head and neck cancer.

Drug Discovery & Development | 24/03/2025 | By Aishwarya |  655

Actinium Pharmaceuticals Announces Research Collaboration with Memorial Sloan Kettering Cancer Center

Actinium Pharmaceuticals has entered a research collaboration with Memorial Sloan Kettering Cancer Center to expand Actimab-A’s mutation-agnostic mechanism in AML through targeted therapy combinations and patient-derived models.

Drug Discovery & Development | 20/03/2025 | By Aishwarya |  236

Nexus Pharmaceuticals Launches Tranexamic Acid

This milestone is another step for Nexus in its mission to provide life-saving medication to those who need it most.

Drug Discovery & Development | 20/03/2025 | By Aishwarya |  464

Akeso Gets NMPA Approval of Penpulimab for Nasopharyngeal Cancer

With this new approval, penpulimab now provides comprehensive treatment coverage across all stages of NPC, offering patients a continuous immunotherapy option from first-line to third-line therapy.

Drug Discovery & Development | 17/03/2025 | By Aishwarya |  525

LGM Pharma Invests USD 6 Million in US Drug Manufacturing Facility

The expansion will increase capacity for liquid, suspension, semi-solid, and suppository drug products, addressing the rising demand for reliable US-based production.

Drug Discovery & Development | 17/03/2025 | By Aishwarya |  391

ENCell Signs MOU with CRC to Enter Japanese Market

Following the latest MoU, the two companies plan to discuss a contractual agreement for the transfer of ENCell’s CDMO technology and expertise.

Drug Discovery & Development | 17/03/2025 | By Aishwarya |  194

Glenmark Unveils Polyethylene Glycol 3350, Powder for Solution, 17 Grams/Capful

Glenmark Pharmaceuticals is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.

Drug Discovery & Development | 10/03/2025 | By Aishwarya |  586

Zydus Lifesciences Introduces ANVIMO for Kidney and HSCT Transplant Patients

CMV infection remains one of the most serious complications in transplant patients, often leading to graft failure, decreased survival and prolonged hospital stays.

Drug Discovery & Development | 06/03/2025 | By Aishwarya |  514

Zydus Lifesciences to Launch Protection Against New Strain of Influenza Virus in India

Zydus is set to launch VaxiFlu-4, India’s first quadrivalent influenza vaccine of the season, formulated as per WHO’s 2025 southern hemisphere recommendations.

Drug Discovery & Development | 01/03/2025 | By Manvi |  632